Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Ionis Pharmaceuticals Q3 Sales $160.00M Beat $143.84M Estimate

Ionis Pharmaceuticals (NASDAQ:IONS) reported quarterly sales of $160.00 million which beat the analyst consensus estimate of $143.84 million by 11.23 percent. This is a 20.30 percent increase over sales of $133.00
byBenzinga Newsdesk
November 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Ionis Pharmaceuticals (NASDAQ:IONS) reported quarterly sales of $160.00 million which beat the analyst consensus estimate of $143.84 million by 11.23 percent. This is a 20.30 percent increase over sales of $133.00 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts